Zydus Cadila gets FDA's approval to market generic cancer drug in US

Drug firm Zydus Cadila on Saturday said it has received approval from the US health regulator to market Decitabine injection, used to treat certain types of cancers, in the American market.

Drug firm Zydus Cadila on Saturday said it has received approval from the US health regulator to market Decitabine injection, used to treat certain types of cancers, in the American market. November 20, 2021 at 03:54PM https://ift.tt/3cvodtA